# io.github.builtforai/loe-exposure

> Drug patent expiries ranked by the Medicare Part D spending exposed to them

- name: io.github.builtforai/loe-exposure
- version: 1.0.0
- connection class: R0 (autonomous)
- trust: 90/100 flags: duplicate-repo
- quality: 79/100 (good)
- owner: not claimed
- descriptor: https://api.protogrid.dev/v1/servers/io.github.builtforai%2Floe-exposure
- tools: https://api.protogrid.dev/v1/servers/io.github.builtforai%2Floe-exposure/tools

**An agent can connect right now, no human step.** Remote endpoint, no authentication, reachable on the last probe.

## Connection (mcpServers)

```json
{
  "mcpServers": {
    "loe-exposure": {
      "type": "http",
      "url": "https://rxfinder.ai/mcp"
    }
  }
}
```


## Trust

- hygiene: 80
- liveness: 99
- freshness: 85
- provenance: 90
- drivers: +repository +namespace-matches-repo +website +reachable +uptime-97% ~updated-32d-ago -duplicate-repo(5 names)
- Derived from observable signals (official registry feed and our own credential-free probes); no code audit performed.

## Quality 79/100 (good)

### protocol: 75 (weight 25)

- warn `protocol.modern`: newest supported version is 2024-11-05; 2026-07-28 not supported, older versions are deprecated until 2027-07-28
- n/a `protocol.stateless`: only applies to 2026-07-28 servers
- pass `protocol.transport`: streamable HTTP
- n/a `protocol.list_ttl`: only applies to 2026-07-28 servers

### authorization: n/a (weight 15)

- n/a `auth.prm`, `auth.as_metadata`, `auth.cimd`: no remote uses OAuth
- n/a `auth.secret_in_url`: no templated URL

### tool hygiene: 71 (weight 30)

- pass `tools.descriptions`: every tool has a description
- pass `tools.description_length`: descriptions are concise
- pass `tools.schemas`: every tool has an object input schema
- fail `tools.annotations`: no tool declares readOnlyHint or destructiveHint, so clients cannot tell safe calls from risky ones
- fail `tools.directory_hints`: no tool declares all four of readOnlyHint, destructiveHint, idempotentHint and openWorldHint; missing: loss_of_exclusivity_exposure (readOnlyHint, destructiveHint, idempotentHint, openWorldHint)
- pass `tools.token_cost`: about 192 tokens to load every tool
- pass `tools.api_dump`: tools are not a one-to-one API dump

### stability: 100 (weight 15)

- pass `stability.changes`: no tool changes in 30 days
- pass `stability.rug_pull`: no tool changed its meaning under the same name

### dependencies: n/a (weight 15)

- n/a `deps.known_vulns`, `deps.mcp_sdk_version`, `deps.resolvable`: no npm or PyPI package

- tools: 1, about 192 tokens to load them all
- tool set hash: 9e169342f3e29a37b5f8b02883f043bd
- badge: [![protogrid quality](https://protogrid.dev/badge/io.github.builtforai/loe-exposure.svg)](https://protogrid.dev/servers/io.github.builtforai/loe-exposure)
- Checks run on what our credential-free, read-only probes observe; tools are never called and no code audit is performed.

### Tool changes

_No tool definition changes recorded._

## Remotes

- https://rxfinder.ai/mcp (streamable-http, auth none, reachable true, uptime30d 0.9655172)

## Packages

_none_

## Tools (1)

- `loss_of_exclusivity_exposure`: Rank upcoming FDA Orange Book patent and exclusivity expiries BY the gross Medicare Part D spending exposed to them, with marketed-generic status for each ranked drug resolved from live CMS NADAC price evidence. Answers which expiries matter, not merely which come first. Reports EXPOSURE, never forecast savings. Spending is gross of manufacturer rebates. Orange Book small molecules only, so biologics — among the largest Part D line items — are excluded, and the headline total must not be read as spending that will "go generic".